US biopharma Biohaven has provided an update regarding the taldefgrobep alfa development programs in spinal muscular atrophy ...

The US Food and Drug Administration (FDA) has accepted for review a Biologics License Application (BLA) for belantamab ...

New research presented at the RSNA meeting suggests that levothyroxine, a common treatment for hypothyroidism, may contribute ...

Cassava Sciences, a US biotech developing a novel, investigational treatment for Alzheimer’s disease (AD) dementia, was ...

Positive top-line results from the Phase III ZENITH study evaluating Winrevair (sotatercept-csrk) in adults with pulmonary ...

UK pharma major AstraZeneca today released positive high-level results from the CAPItello-281 Phase III trial showing that ...

Lexicon Pharmaceuticals is shifting focus to its late-stage pipeline following the FDA's rejection of Zynquista for type 1 ...

Specialist preclinical contract research organization (CRO) and ion channel screening company Metrion Biosciences has ...

Danish biotech Adcendo today announced the successful closing of an oversubscribed $135 million Series B financing round. The ...

In what could be construed to be India's quest for pharmaceutical supremacy, a clarion call has been made for the country to ...

Centauri Therapeutics secured a £1 million ($1.25 million) grant from PACE to advance its Alphamer technology, targeting ...

The US Food and Drug Administration (FDA) on Friday approved Attruby (acoramidis), an orally-administered near-complete (≥90% ...